Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2010
11/03/2010CN1919251B Traditional Chinese medicine composition for treating cardiac vascular disease
11/03/2010CN1876004B A medicament for treating cerebrovascular disease
11/03/2010CN1872144B Drop pills of kudzuvine root, and preparation method
11/03/2010CN1872053B Drop pills of daphnetin, and preparation method
11/03/2010CN1812812B Serum cholesterol lowering agnet or preventive or therapeutic agent for atherosclerosis
11/03/2010CN1368888B Anti-human mitochondrial a denylate kinase isozyme antibody, diagnostic formulation and diagnostic kit for cardiac disease
11/03/2010CN101878201A Fused indane compound
11/03/2010CN101877961A Use of neuregulin for organ preservation
11/03/2010CN101875961A Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related therto
11/03/2010CN101875684A Compound with functions of blocking cholesterol esterification and lowering cholesterol
11/03/2010CN101875617A Carbamyl aromatic acid compound with alkoxy replacing aromatic ring, preparation method and application thereof
11/03/2010CN101874893A Health-care medicinal liquor
11/03/2010CN101874891A Chinese medicinal composition for treating heart-throb and preparation method thereof
11/03/2010CN101874887A Chinese medicinal composition for treating angina and preparation method thereof
11/03/2010CN101874876A Tibetan Mastiff gall traditional Chinese medicine for refreshment and preparation method thereof.
11/03/2010CN101874875A Chinese medicinal tea for treating hypertension, hyperlipoidemia and high blood viscosity and preparation method thereof
11/03/2010CN101874871A Medicine combination for promoting blood circulation and supplementing qi and nourishing yin and preparation method thereof
11/03/2010CN101874869A Method for measuring loganin content of Chinese medicinal composition
11/03/2010CN101874861A Medicament for treating and preventing heart diseases, preparation method and application method thereof
11/03/2010CN101874848A Digitalis extract, preparation method and application thereof
11/03/2010CN101874835A Oral Chinese medicinal formula for treating thromboangitis obliterans
11/03/2010CN101874829A Medicament for treating cardiovascular and cerebrovascular diseases and preparation method thereof
11/03/2010CN101874824A Active extract containing trilobatin and application thereof
11/03/2010CN101874818A Medicament or health-care product composition for reducing blood pressure or blood fat and preparation method and application thereof
11/03/2010CN101874802A Slow-release medicinal composition for treating hypertension and high cholesterol
11/03/2010CN101874784A Crystal separating drug sustained-release microspherule and preparation method thereof
11/03/2010CN101874776A Dry emulsion of vinpocetine and preparation method thereof
11/03/2010CN101632656B Preparation method of water-soluble irisolidone
11/03/2010CN101366910B Traditional Chinese medicine for treating frequent premature beat
11/03/2010CN101313989B Chinese medicinal composition for treating coronary disease, stenocardia
11/03/2010CN101313910B Preparation technique for sodium phosphocreatine freeze-dried injection
11/03/2010CN101279076B Medicinal liquor for cleaning vascular lipids and preventing cerebrovascular disease
11/03/2010CN101230035B Aspartic acid amlodipine series salt as well as preparation method, composition, preparation and tablets thereof
11/03/2010CN101203224B Use of pyrimidylaminobenzamides for the treatment of diseases that respond to modulation of Tie-2 kinase activity
11/03/2010CN101124991B Health-care bag beverage capable of preventing high blood pressure
11/03/2010CN101103966B Omega-3 falty acid-garlic oil capsule and manufacturing method thereof
11/03/2010CN101028338B Oral-cavity disintegrating tablet for treating cardiovascular disease
11/03/2010CN101002828B Method for preparing Danhong injection, and products thereof
11/02/2010US7825255 Adenosine receptor selective modulators
11/02/2010US7825219 Binding protein; therapy for bone tumors
11/02/2010US7825216 Phenylanine derivatives
11/02/2010US7825146 Sulfonamide derivative having isoxazole ring
11/02/2010US7825129 Thieno[2,3-c] isoquinolines for use as inhibitors of PARP
11/02/2010US7825126 (N)-methanocarba adenine nucleosides contemplated for use in the treatment a number of diseases, for example, inflammation, cardiac ischemia, stroke, asthma, diabetes, cardiac arrhythmias and cardioprotection
11/02/2010US7825113 2-oxy-benzoxazinone derivatives for the treatment of obesity
11/02/2010US7825111 Substituted spiroheterocycles
11/02/2010US7825110 Substituted spiroheterocycles
11/02/2010US7825105 such as 3,10-Dibenzyloxyminocycline, used to treat bacterial infections and neoplasms, as well as blocking tetracycline efflux and modulation of gene expression
11/02/2010US7824677 inhibiting blood coagulation mediated by factor X binding to tissue factor; provide superior anti-coagulant activity by binding native human tissue factor with high affinity and specificity; linked covalently to a cell antigen or an effector molecule to provide complement fixing ability
11/02/2010CA2470391C N,n'-disubstituted piperazine compounds and their use as analgesics
11/02/2010CA2462799C Pyrimidine derivatives
11/02/2010CA2460121C 3-substituted-4-pyrimidone derivatives
11/02/2010CA2439784C Pyrazolopyrimidinone derivatives having pde7 inhibiting action
11/02/2010CA2437715C Carboline derivatives
11/02/2010CA2436361C Angiotensin ii antagonistic compound for use as analgesic and antiinflammatory agent
11/02/2010CA2417432C Modified polypeptides stabilized in a desired conformation and methods for producing same
11/01/2010CA2665302A1 Cd36 modulation and uses thereof
10/2010
10/28/2010WO2010124201A2 Compositions and methods for treatment of cardiovascular disease
10/28/2010WO2010123156A1 Angiogenesis inhibitor
10/28/2010WO2010123139A1 Arylcarboxamide derivative having sulfamoyl group
10/28/2010WO2010123047A1 Crystal of benzoxazinone compound
10/28/2010WO2010122980A1 Novel thyroid hormone β receptor agonist
10/28/2010WO2010122504A1 Thiazole derivatives and their use as p2y12 receptor antagonists
10/28/2010WO2010096264A9 Methods for enhancing hematopoietic stem/progenitor cell engraftment
10/28/2010WO2010078325A3 Natriuretic polypeptides for reducing or preventing restenosis
10/28/2010WO2010078285A3 Pharmaceutical compositions and methods of treating neurological insults
10/28/2010WO2010068815A3 Compositions and methods for treating cellular proliferative disorders
10/28/2010WO2010058426A3 Inhibition of vegf-a secretion, angiogenesis and/or neoangiogenesis by sina mediated knockdown of vegf-c and rhoa
10/28/2010WO2009127338A8 Oxo-heterocyclic substituted carboxylic acid derivates and the use thereof
10/28/2010US20100273891 Isoflavone metabolites
10/28/2010US20100273886 Formulations and methods for lyophilization and lyophilates provided thereby
10/28/2010US20100273882 Use of adapalene gel or cream
10/28/2010US20100273868 R-Zileuton for Use in Conditions Associated with Increased 5-Lipoxygenase and/or Leukotriene Activity (EG Asthma)
10/28/2010US20100273862 Phosphatases which activate map kinase pathways
10/28/2010US20100273860 MODULATION OF APOLIPOPROTEIN (a) EXPRESSION
10/28/2010US20100273858 Compositions comprising stat5 sirna and methods of use thereof
10/28/2010US20100273852 Pharmaceutical composition
10/28/2010US20100273850 4-heteroaryl-substituted phenoxyphenylacetic acid derivatives
10/28/2010US20100273849 Metalloproteinase Inhibitors
10/28/2010US20100273845 Angiotensin ii receptor antagonists
10/28/2010US20100273835 Novel compounds
10/28/2010US20100273831 Fluoro alkyl substituted benzimidazole cannabinoid agonists
10/28/2010US20100273829 Methods for Treating Disorders Associated with Hyperlipidemia in a Mammal
10/28/2010US20100273824 Substituted 1,3-dioxanes and their uses
10/28/2010US20100273816 Quinazoline Compounds
10/28/2010US20100273809 Method and composition for treating an alpha adrenoceptor-mediated condition
10/28/2010US20100273807 Use of PDE III Inhibitors for the Treatment of Asymptomatic (Occult) Heart Failure
10/28/2010US20100273797 Alpha-ketoamides and derivatives thereof
10/28/2010US20100273794 Benzimidazolone Compounds Having 5-HT4 Receptor Agonistic Activity
10/28/2010US20100273790 Processes for the preparation of rivaroxaban and intermediates thereof
10/28/2010US20100273782 2,5-disubstituted arylsulfonamide ccr3 antagonists
10/28/2010US20100273781 Cxcr3 receptor antagonists
10/28/2010US20100273779 Pyridazinone Derivatives
10/28/2010US20100273767 Modulators of 5-ht receptors and methods of use thereof
10/28/2010US20100273766 Substituted oxindol derivatives, medicaments containing said derivatives and use thereof
10/28/2010US20100273765 Rifamycin analogs and uses thereof
10/28/2010US20100273761 Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosis
10/28/2010US20100273760 Topical Pharmaceutical Formulations And Methods Of Treatment
10/28/2010US20100273757 Pyrazine derivatives useful as adenosine receptor antagonists
10/28/2010US20100273754 Organic compounds
1 ... 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 ... 1595